-
Office worker wins £22,000 payout after boss said his firm would need to 'chart a different path' when she took time off with Crohn's disease
06 Aug 2025 12:39 GMT
An accountancy firm worker with Crohn's disease has won more than £22,000 in a discrimination claim after her boss said the company needed to 'chart a different path' when she needed time off for treatment.
Ozgul Coban had been in the job for …
-
Inflammatory diets, ultra-processed foods may increase Crohn's disease…
01 Aug 2025 16:09 GMT
Inflammatory bowel disease (IBD) is a group of chronic conditions that damage the intestines and can cause uncomfortable symptoms.
Preventing IBD remains a challenge, and research is underway to minimize this risk.
A recent systematic review and meta- …
-
Polpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio
06 Aug 2025 16:27 GMT
Europe-based Polpharma Biologics announced on Aug. 5, 2025, that it has entered into a global licensing agreement with Fresenius Kabi to commercialize PB016, Polpharma Biologics’ proposed biosimilar to vedolizumab (brand name Entyvio) (1), Takeda …
-
Body Composition Tied to Post-Surgery Outcomes in Crohn's
06 Aug 2025 17:37 GMT
TOPLINE:
In patients with Crohn's disease (CD) who underwent ileocolic resection (ICR), preoperative myosteatosis (high lipid content in skeletal muscles) was associated with postoperative complications; low subcutaneous adipose tissue levels …
-
C. Diff Infections: What To Know About This Gut Bacteria
06 Aug 2025 12:15 GMT
Latest Infectious Disease News
By Cedrek McFadden, MD, FACS, FACRS HealthDay Reporter
TUESDAY, August 5, 2025 — C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one …
-
Rising Incidences, Misconceptions, and Unmet Needs Warrant Awareness for Appendix Cancer
06 Aug 2025 05:33 GMT
Among rare and understudied tumor types lies appendiceal cancer, of which the incidence has increased since 2010 without much explanation, according to Rosario Ligresti, MD, FASGE.
In a retrospective study published in Cancer, data revealed that between …
-
Polpharma Biologics & Fresenius Kabi enter licensing agreement for proposed vedolizumab biosimilar, PB016
06 Aug 2025 05:31 GMT
Polpharma Biologics SA (Polpharma Biologics), an international biotechnology company with integrated operations in the European Union, announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the …
-
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
05 Aug 2025 20:02 GMT
Reported positive interim Phase 1 results for two next-generation TL1A antibodies, demonstrating both were well-tolerated, exhibited pharmacokinetic ("PK") profiles supporting quarterly or biannual dosing, and full TL1A engagement through up to …
-
New endoscopy centers to increase affordability, accessibility of colonoscopy
05 Aug 2025 01:15 GMT
SANDY — More people are experiencing chronic digestive health conditions and colon cancer is being diagnosed at younger ages, prompting one of Utah's largest health care companies to increase options to treat them.
Intermountain Health is opening free- …
-
Anastacia oozes stage presence during high-energy gig at iconic venue
04 Aug 2025 16:10 GMT
Thousands of people flocked to Halifax's beautiful Piece Hall to enjoy a tremendous gig from the global pop superstar, who is touring the world to celebrate 25 years since the release of her hit debut album, Not That Kind.
"This is a beautiful …